Atlas Trials

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

Clinical trial NCT02240719 · COMPLETED

Trial details

NCT number
NCT02240719
Sponsor
University of California, Davis
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell LymphomaRefractory Chronic Lymphocytic LeukemiaMultiple Myeloma
Start date
2014-10-01
Primary completion
2018-04-09
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.